© 2024 Intra-Cellular Therapies Inc. All rights reserved.
SEC Filing Details
Document Details
Form
Filing Date
Mar 14, 2022
Document Date
Mar 10, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Intra-Cellular Therapies Inc.
Issuer
INTRA-CELLULAR THERAPIES, INC.
Filer
Halstead Michael